These findings implied that RCC2 may play an oncogenic role in many cancer types, and high expression of RCC2 was correlated with a poorer survival outcome in hepatocellular carcinoma, which was in line with previous studies [6, 12]. The gene discussed is RCC2; the disease is cancer.